Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Recurrent Uterine Corpus Carcinoma × Filgrastim × 90 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Leukemia, Biphenotypic, Acute 6 Myelodysplastic Syndromes 5 Hodgkin Disease 5 Breast Neoplasms 5 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Neoplasms 4 Lymphoma, Large B-Cell, Diffuse 4 Hematologic Neoplasms 4 Burkitt Lymphoma 4 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Medulloblastoma 2 Lymphoma 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia 2 Triple Negative Breast Neoplasms 1 Teratoma 1 Sarcoma, Ewing 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Rhabdomyosarcoma 1 Recurrence 1 Osteosarcoma 1 Multi-centric Castleman's Disease 1 Macular dystrophy, corneal type 1 1 Lymphoproliferative Disorders 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡